Kaleido Biosciences Probability of Future Pink Sheet Price Finishing Under 0.07

KLDODelisted Stock  USD 0.01  0.00  0.00%   
Kaleido Biosciences' future price is the expected price of Kaleido Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kaleido Biosciences performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
  
Please specify Kaleido Biosciences' target price for which you would like Kaleido Biosciences odds to be computed.

Kaleido Biosciences Target Price Odds to finish below 0.07

The tendency of Kaleido Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 0.07  after 90 days
 0.01 90 days 0.07 
close to 99
Based on a normal probability distribution, the odds of Kaleido Biosciences to stay under $ 0.07  after 90 days from now is close to 99 (This Kaleido Biosciences probability density function shows the probability of Kaleido Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Kaleido Biosciences price to stay between its current price of $ 0.01  and $ 0.07  at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days Kaleido Biosciences has a beta of -63.38. This indicates as returns on its benchmark rise, returns on holding Kaleido Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Kaleido Biosciences is expected to outperform its benchmark. In addition to that Kaleido Biosciences has an alpha of 94.8762, implying that it can generate a 94.88 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Kaleido Biosciences Price Density   
       Price  

Predictive Modules for Kaleido Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kaleido Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kaleido Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.010.010.01
Details
Naive
Forecast
LowNextHigh
0.010.010.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kaleido Biosciences. Your research has to be compared to or analyzed against Kaleido Biosciences' peers to derive any actionable benefits. When done correctly, Kaleido Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Kaleido Biosciences.

Kaleido Biosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Kaleido Biosciences is not an exception. The market had few large corrections towards the Kaleido Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kaleido Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kaleido Biosciences within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
94.88
β
Beta against NYSE Composite-63.38
σ
Overall volatility
0
Ir
Information ratio 0.14

Kaleido Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kaleido Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kaleido Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kaleido Biosciences is not yet fully synchronised with the market data
Kaleido Biosciences has some characteristics of a very speculative penny stock
Kaleido Biosciences has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.1 M. Net Loss for the year was (90.29 M) with loss before overhead, payroll, taxes, and interest of (66.7 M).
Kaleido Biosciences currently holds about 38.47 M in cash with (77.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Kaleido Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kaleido Pink Sheet often depends not only on the future outlook of the current and potential Kaleido Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kaleido Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding33.5 M
Cash And Short Term Investments38.5 M

Kaleido Biosciences Technical Analysis

Kaleido Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Kaleido Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kaleido Biosciences. In general, you should focus on analyzing Kaleido Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Kaleido Biosciences Predictive Forecast Models

Kaleido Biosciences' time-series forecasting models is one of many Kaleido Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kaleido Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Kaleido Biosciences

Checking the ongoing alerts about Kaleido Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kaleido Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kaleido Biosciences is not yet fully synchronised with the market data
Kaleido Biosciences has some characteristics of a very speculative penny stock
Kaleido Biosciences has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.1 M. Net Loss for the year was (90.29 M) with loss before overhead, payroll, taxes, and interest of (66.7 M).
Kaleido Biosciences currently holds about 38.47 M in cash with (77.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Kaleido Pink Sheet

If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine